Lining up a filing for lead ROS1 inhibitor, transpacific oncology biotech AnHeart Therapeutics raises $61M
In China, the character 安, pronounced An in English phonics, has a few different translations — yet they all come to the same general meaning: calm, safe, comfortable.
And for precision oncology biotech AnHeart Therapeutics, that Chinese character helps to define the company’s objective.
“In Chinese, the pronunciation actually means something — [it] has special meaning: calm, safe, comfortable. So it’s really — you have a very calm heart, comfortable heart full of patients. So we try to make medicine so the patient can feel comfortable, feel safe. Feel calm,” AnHeart CBO and co-founder Lihua Zheng told Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.